CLGN
CollPlant Biotechnologies Ltd.
0.34
1 x 0.61
1 x 0.38
bid
ask
-
0.01
2.46%
1 @ 04:00 PM
0.35 +0.01 (2.67%)
| Ytd | -75.69% | |
| 1y | -74.79% |
0.33
day range
0.37
0.27
52 week range
3.23
| Open | 0.34 | Prev Close | 0.35 | Low | 0.33 | High | 0.37 | Mkt Cap | 4.91M |
| Vol | 19.28K | Avg Vol | 98.46K | EPS | -1.04 | P/E | N/A | Forward P/E | -8.82 |
| Beta | 0.48 | Short Ratio | 0.70 | Inst. Own | 12.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-19 | 50-d Avg | 0.38 | 200-d Avg | 1.25 | 1yr Est | 12.50 |
| Income Statement | |||
| Total Revenue | 73.00K | ||
| Revenues (USD) | 73.00K | ||
| Cost of Revenue | 316.00K | ||
| Gross Profit | -243.00K | ||
| Operating Expenses | 2.87M | ||
| Research and Development Expense | 1.68M | ||
| Selling, General and Administrative Expense | 1.19M | ||
| Operating Income | -3.11M | ||
| Interest Expense | -18.00K | ||
| Net Income | -3.10M | ||
| Net Income Common Stock | -3.10M | ||
| Net Income Common Stock (USD) | -3.10M | ||
| Consolidated Income | -3.10M | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.23 | ||
| Earning Before Interest & Taxes (EBIT) | -3.11M | ||
| Earning Before Interest & Taxes (USD) | -3.11M | ||
| Weighted Average Shares | 13.75M | ||
| Weighted Average Shares Diluted | 13.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.26M | ||
| Cash and Equivalents (USD) | 4.26M | ||
| Trade and Non-Trade Receivables | 233.00K | ||
| Current Assets | 5.54M | ||
| Property, Plant & Equipment Net | 3.51M | ||
| Total Assets | 9.18M | ||
| Debt Current | 794.00K | ||
| Total Debt | 2.65M | ||
| Current Liabilities | 2.44M | ||
| Debt Non-Current | 1.86M | ||
| Total Liabilities | 4.30M | ||
| Accumulated Retained Earnings (Deficit) | -127.94M | ||
| Accumulated Other Comprehensive Income | -969.00K | ||
| Shareholders Equity | 4.89M | ||
| Shareholders Equity (USD) | 4.89M | ||
| Assets Non-Current | 3.64M | ||
| Total Debt (USD) | 2.65M | ||
| Goodwill and Intangible Assets | 59.00K | ||
| Inventory | 679.00K | ||
| Liabilities Non-Current | 1.86M | ||
| Trade and Non-Trade Payables | 635.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 210.00K | ||
| Net Cash Flow from Financing | 1.72M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.33M | ||
| Capital Expenditure | -6.00K | ||
| Issuance (Purchase) of Equity Shares | 1.72M | ||
| Net Cash Flow from Investing | -6.00K | ||
| Net Cash Flow from Operations | -3.05M | ||
| Effect of Exchange Rate Changes on Cash | 7.00K | ||
| Share Based Compensation | 180.00K | ||